Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

To kiss or not to kiss in the era of the human papillomavirus-associated head and neck cancer "epidemic"?

Rettig EM, Fakhry C, Nathan CO.

Laryngoscope. 2018 Sep 8. doi: 10.1002/lary.27277. [Epub ahead of print] No abstract available.

PMID:
30194848
2.

When Should Parotidectomy and a Neck Dissection Be Performed in Cutaneous SCC of the Head and Neck?

Asarkar A, Bundrick P, Nathan CO.

Laryngoscope. 2018 Sep 8. doi: 10.1002/lary.27274. [Epub ahead of print] No abstract available.

PMID:
30194846
3.

A pilot study of Merkel cell polyomavirus in squamous cell carcinoma of the tongue.

Hamiter M, Asarkar A, Rogers D, Moore-Medlin T, McClure G, Ma X, Vanchiere J, Nathan CO.

Oral Oncol. 2017 Nov;74:111-114. doi: 10.1016/j.oraloncology.2017.09.021. Epub 2017 Oct 4. No abstract available.

PMID:
29103738
4.

Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.

Mehta V, Moore-Medlin T, Flores JM, Ma X, Ekshyyan O, Nathan CO.

Oncotarget. 2017 Aug 10;8(41):70907-70915. doi: 10.18632/oncotarget.20197. eCollection 2017 Sep 19.

5.

In response to Does mutational analysis influence the management of differentiated thyroid cancers?

Nathan CO, Asarkar A, Shaha M, Shaha A.

Laryngoscope. 2018 Feb;128(2):E85. doi: 10.1002/lary.26842. Epub 2017 Aug 22. No abstract available.

PMID:
28833249
6.

Does mutational analysis influence the management of differentiated thyroid cancers?

Asarkar A, Shaha M, Shaha A, Nathan CO.

Laryngoscope. 2018 Jan;128(1):1-2. doi: 10.1002/lary.26650. Epub 2017 May 17. Review. No abstract available.

PMID:
28514497
7.

Incidence of contralateral-bilateral nodes in the human papillomavirus era.

Tritter AG, Mehta V, Samuelson M, deGravelle G, Ma X, Medlin-Moore T, Takalkar A, Caldito G, Nathan CO.

Laryngoscope. 2017 Jun;127(6):1328-1333. doi: 10.1002/lary.26439. Epub 2016 Dec 1.

PMID:
27905120
8.

Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.

Ekshyyan O, Khandelwal AR, Rong X, Moore-Medlin T, Ma X, Alexander JS, Nathan CO.

Am J Transl Res. 2016 Nov 15;8(11):4822-4830. eCollection 2016.

9.

Intermittently symptomatic tracheal diverticulum: a case of a rare clinical phenomenon.

Smelley CL, Bowen R, Nathan CO.

Ear Nose Throat J. 2011 Sep;90(9):E10-2.

PMID:
21938686
10.

Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.

Sunavala-Dossabhoy G, Palaniyandi S, Clark C, Nathan CO, Abreo FW, Caldito G.

Laryngoscope. 2011 Oct;121(10):2136-41. doi: 10.1002/lary.22144. Epub 2011 Sep 6.

PMID:
21898433
11.

Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan.

Pattani KM, Goodier M, Lilien D, Kupferman T, Caldito G, Nathan CO.

Ear Nose Throat J. 2011 Aug;90(8):E16-20.

PMID:
21853427
12.

Efficacy and comparative effectiveness of sirolimus as an anticancer drug.

Hu M, Ekshyyan O, Herman Ferdinandez L, Rong X, Caldito G, Nathan CO.

Laryngoscope. 2011 May;121(5):978-82. doi: 10.1002/lary.21724.

13.

Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease.

Gill MT, Dean M, Karr J, Aultman DF, Nathan CO.

Otolaryngol Head Neck Surg. 2011 May;144(5):691-7. doi: 10.1177/0194599811398597.

PMID:
21493339
14.

Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.

Compton AM, Moore-Medlin T, Herman-Ferdinandez L, Clark C, Caldito GC, Wang XI, Thomas J, Abreo FW, Nathan CO.

Otolaryngol Head Neck Surg. 2011 Jul;145(1):51-7. doi: 10.1177/0194599811400385.

PMID:
21493313
15.

Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo.

Phillips JM, Clark C, Herman-Ferdinandez L, Moore-Medlin T, Rong X, Gill JR, Clifford JL, Abreo F, Nathan CO.

Otolaryngol Head Neck Surg. 2011 Jul;145(1):58-63. doi: 10.1177/0194599811400711.

PMID:
21493306
16.

Timing of esophageal dilation for dysphagia in head and neck cancer patients receiving radiation therapy.

Cho AH, Caldito G, Nathan CO.

Laryngoscope. 2010;120 Suppl 4:S145. doi: 10.1002/lary.21609.

PMID:
21225743
17.

Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.

Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.

Cancer Prev Res (Phila). 2010 Dec;3(12):1586-95. doi: 10.1158/1940-6207.CAPR-09-0244. Epub 2010 Sep 17.

18.

Tracheal non-Hodgkin's lymphoma masquerading as benign granulation tissue: a report of two cases.

Gill MT, Cotelingam JD, Lowery-Nordberg M, Nathan CO.

Ann Otol Rhinol Laryngol. 2010 Jul;119(7):431-5.

PMID:
20734962
19.

A unique case of a sublingual-space schwannoma arising from the mylohyoid nerve.

Pattani KM, Dowden K, Nathan CO.

Ear Nose Throat J. 2010 Jul;89(7):E31-3.

PMID:
20628977
20.

Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.

Clark C, Shah S, Herman-Ferdinandez L, Ekshyyan O, Abreo F, Rong X, McLarty J, Lurie A, Milligan EJ, Nathan CO.

Laryngoscope. 2010 Jun;120(6):1159-65. doi: 10.1002/lary.20917.

21.

Electrical stimulation of post-irradiated head and neck squamous cell carcinoma to improve xerostomia.

Pattani KM, McDuffie CM, Morgan M, Armstrong C, Nathan CO.

J La State Med Soc. 2010 Jan-Feb;162(1):21-5.

PMID:
20336953
22.

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.

Ekshyyan O, Mills GM, Lian T, Amirghahari N, Rong X, Lowery-Nordberg M, Abreo F, Veillon DM, Caldito G, Speicher L, Glass J, Nathan CO.

Head Neck. 2010 Dec;32(12):1619-28. doi: 10.1002/hed.21374.

PMID:
20222045
23.

Radiologic findings after successful chemoradiation for nasopharyngeal cancer with skull base erosion.

Ampil F, Sangster G, Mills G, Nathan CO, Lian T, Hall A.

Ear Nose Throat J. 2010 Jan;89(1):38-41. Erratum in: Ear Nose Throat J. 2010 Oct;89(10):486. Nathan, Cherie Ann [corrected to Nathan, Cherie-Ann O].

PMID:
20155699
24.

N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?

Cho AH, Shah S, Ampil F, Bhartur S, Nathan CO.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1112-8. doi: 10.1001/archoto.2009.148.

PMID:
19917924
25.

Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Ekshyyan O, Rong Y, Rong X, Pattani KM, Abreo F, Caldito G, Chang JK, Ampil F, Glass J, Nathan CO.

Mol Cancer Ther. 2009 Aug;8(8):2255-65. doi: 10.1158/1535-7163.MCT-08-1184. Epub 2009 Jul 22.

26.

Reflux as a cause of tracheoesophageal puncture failure.

Pattani KM, Morgan M, Nathan CO.

Laryngoscope. 2009 Jan;119(1):121-5. doi: 10.1002/lary.20052.

PMID:
19117290
27.

Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.

Jiang R, Gu X, Nathan CO, Hutt-Fletcher L.

J Oral Pathol Med. 2008 Nov;37(10):626-33. doi: 10.1111/j.1600-0714.2008.00681.x. Epub 2008 Aug 15.

28.

Pilot randomized phase II study of celecoxib in oral premalignant lesions.

Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.

Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.

29.

Return of vocal cord movement: an independent predictor of response to nonsurgical management of laryngeal cancers.

Iloabachie K, Nathan CO, Ampil F, Morgan ML, Caldito G.

Laryngoscope. 2007 Nov;117(11):1925-9.

PMID:
17828050
30.

Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer.

Nathan CO, Amirghahari N, Rong X, Giordano T, Sibley D, Nordberg M, Glass J, Agarwal A, Caldito G.

Cancer Res. 2007 Mar 1;67(5):2160-8.

31.

Total laryngectomy and T3-T4 laryngeal cancer without other adverse histopathology.

Ampil FL, Nathan CO, Lian TS, Caldito G, Milligan E.

Otolaryngol Head Neck Surg. 2007 Feb;136(2):296-300.

PMID:
17275558
32.

The voice-controlled robotic assist scope holder AESOP for the endoscopic approach to the sella.

Nathan CO, Chakradeo V, Malhotra K, D'Agostino H, Patwardhan R.

Skull Base. 2006 Aug;16(3):123-31.

33.

Squamous cell carcinoma of the oral cavity following breast cancer treatment.

Ye G, Burton GV, Nathan CO, Ampil FL.

South Med J. 2006 Oct;99(10):1150-1. No abstract available.

PMID:
17100048
34.

Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.

Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.

J Gene Med. 2006 Sep;8(9):1105-20.

PMID:
16802401
35.

Predictive factors for posterior triangle metastasis in HNSCC.

McDuffie CM, Amirghahari N, Caldito G, Lian TS, Thompson L, Nathan CO.

Laryngoscope. 2005 Dec;115(12):2114-7.

PMID:
16369153
36.

Anaplastic thyroid cancer and hyperthyroidism.

Kumar V, Blanchon B, Gu X, Fowler M, Scarborough D, Nathan CO, Yaturu S.

Endocr Pathol. 2005 Fall;16(3):245-50.

PMID:
16299408
37.

Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.

Moody CA, Scott RS, Amirghahari N, Nathan CO, Young LS, Dawson CW, Sixbey JW.

J Virol. 2005 May;79(9):5499-506.

38.

Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx.

Lee M, Ramaswamy MR, Lilien DL, Nathan CO.

Ann Otol Rhinol Laryngol. 2005 Mar;114(3):202-6.

PMID:
15825569
39.

Botulinum toxin: helpful adjunct to early resolution of laryngeal granulomas.

Pham J, Yin S, Morgan M, Stucker F, Nathan CO.

J Laryngol Otol. 2004 Oct;118(10):781-5.

PMID:
15550184
40.

Head and neck cancer with simultaneous lung cancer.

Ampil FL, Mills GM, Heldmann M, Nathan CO.

J La State Med Soc. 2004 Jul-Aug;156(4):193-5.

PMID:
15366347
41.

Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.

Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J.

Clin Cancer Res. 2004 Sep 1;10(17):5820-7.

42.

A pilot study of quantitative aspiration in patients with symptoms of obstructive sleep apnea: comparison to a historic control group.

Beal M, Chesson A, Garcia T, Caldito G, Stucker F, Nathan CO.

Laryngoscope. 2004 Jun;114(6):965-8.

PMID:
15179196
43.

Aggressive fibromatosis of the parapharyngeal space: two cases and treatment recommendations.

Sanders KW, Fowler MR, Milner J, Stucker FJ, Nathan CO.

Ear Nose Throat J. 2004 Apr;83(4):262, 264, 266 passim.

PMID:
15147097
44.

Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: a 14-year review.

Ampil FL, Nathan CO, Caldito G, Lian TF, Aarstad RF, Krishnamsetty RM.

Am J Otolaryngol. 2004 Mar-Apr;25(2):88-93.

PMID:
14976652
45.

NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.

Amirghahari N, Harrison L, Smith M, Rong X, Naumann I, Ampil F, Shi R, Glass J, Nathan CO.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1405-12.

PMID:
14630280
46.

Postoperative radiotherapy for insecure or positive surgical margins in head and neck cancer.

Ampil FL, Caldito G, Ghali GE, Nathan CO.

J Oral Maxillofac Surg. 2003 Apr;61(4):425-9.

PMID:
12684958
47.

Positive response of advanced oropharyngeal cancer with trismus to chemoradiation.

Ampil FL, Mills GM, Nathan CO, Burton GV, Mansour R, Hardjasudarma M.

South Med J. 2003 Mar;96(3):316-7. No abstract available.

PMID:
12659368
48.

Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. An argument for the use of adjuvant chemotherapy.

Ampil FL, Borski TG, Nathan CO, Mulcahy G, Walker M, Chin HW, Stucker FJ.

Leuk Lymphoma. 2002 Oct;43(10):2037-40. Review.

PMID:
12481905
49.

Salvage treatment of recurrent skin cancer of the midface.

Ampil FL, Nathan CO, Lian TF, Stucker FJ, Hardin JC Jr, Aarstad RF.

Am J Clin Oncol. 2002 Dec;25(6):580-2.

PMID:
12478003
50.

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.

Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.

Laryngoscope. 2002 Dec;112(12):2129-40.

PMID:
12461330

Supplemental Content

Loading ...
Support Center